China Resources Sanjiu Medical & Pharmaceutical Co Ltd (000999) - Cash Flow Conversion Efficiency
Based on the latest financial reports, China Resources Sanjiu Medical & Pharmaceutical Co Ltd (000999) has a cash flow conversion efficiency ratio of 0.003x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥126.71 Million ≈ $18.54 Million USD) by net assets (CN¥37.38 Billion ≈ $5.47 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see China Resources Sanjiu Medical & Pharmac market cap and net worth for the company's overall valuation and market capitalisation.
China Resources Sanjiu Medical & Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (1999–2024)
This chart illustrates how China Resources Sanjiu Medical & Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
China Resources Sanjiu Medical & Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of China Resources Sanjiu Medical & Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Explore China Resources Sanjiu Medical & Pharmac (000999) cash earnings ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Guangdong Shenling Environmental Systems Co. Ltd.
SHE:301018
|
0.038x |
|
Linde India Limited
NSE:LINDEINDIA
|
0.093x |
|
Bank of Changsha Co Ltd
SHG:601577
|
1.054x |
|
Yunnan Wenshan Electric Power Co Ltd
SHG:600995
|
0.050x |
|
Capital Financial Indonesia Tbk PT
JK:CASA
|
-0.145x |
|
MarketAxess Holdings Inc
NASDAQ:MKTX
|
0.021x |
|
Dropbox Inc
NASDAQ:DBX
|
-0.131x |
|
Telecom Italia S.p.A
F:TQIR
|
0.082x |
Annual Cash Flow Conversion Efficiency for China Resources Sanjiu Medical & Pharmaceutical Co Ltd (1999–2024)
The table below shows the annual cash flow conversion efficiency of China Resources Sanjiu Medical & Pharmaceutical Co Ltd from 1999 to 2024. View China Resources Sanjiu Medical & Pharmac stock quote for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥25.26 Billion ≈ $3.70 Billion |
CN¥4.40 Billion ≈ $644.18 Million |
0.174x | +0.20% |
| 2023-12-31 | CN¥24.26 Billion ≈ $3.55 Billion |
CN¥4.22 Billion ≈ $617.58 Million |
0.174x | +1.45% |
| 2022-12-31 | CN¥17.53 Billion ≈ $2.57 Billion |
CN¥3.01 Billion ≈ $439.93 Million |
0.171x | +44.03% |
| 2021-12-31 | CN¥15.71 Billion ≈ $2.30 Billion |
CN¥1.87 Billion ≈ $273.72 Million |
0.119x | -24.75% |
| 2020-12-31 | CN¥14.06 Billion ≈ $2.06 Billion |
CN¥2.22 Billion ≈ $325.44 Million |
0.158x | +3.34% |
| 2019-12-31 | CN¥12.88 Billion ≈ $1.89 Billion |
CN¥1.97 Billion ≈ $288.54 Million |
0.153x | -10.55% |
| 2018-12-31 | CN¥11.17 Billion ≈ $1.63 Billion |
CN¥1.91 Billion ≈ $279.68 Million |
0.171x | +11.04% |
| 2017-12-31 | CN¥10.12 Billion ≈ $1.48 Billion |
CN¥1.56 Billion ≈ $228.33 Million |
0.154x | -3.45% |
| 2016-12-31 | CN¥8.72 Billion ≈ $1.28 Billion |
CN¥1.39 Billion ≈ $203.71 Million |
0.160x | -2.77% |
| 2015-12-31 | CN¥7.67 Billion ≈ $1.12 Billion |
CN¥1.26 Billion ≈ $184.35 Million |
0.164x | -3.04% |
| 2014-12-31 | CN¥7.00 Billion ≈ $1.02 Billion |
CN¥1.18 Billion ≈ $173.32 Million |
0.169x | -26.61% |
| 2013-12-31 | CN¥6.36 Billion ≈ $930.82 Million |
CN¥1.47 Billion ≈ $214.73 Million |
0.231x | +6.15% |
| 2012-12-31 | CN¥5.58 Billion ≈ $815.96 Million |
CN¥1.21 Billion ≈ $177.33 Million |
0.217x | +10.39% |
| 2011-12-31 | CN¥4.85 Billion ≈ $709.79 Million |
CN¥954.90 Million ≈ $139.73 Million |
0.197x | +3.59% |
| 2010-12-31 | CN¥4.46 Billion ≈ $653.19 Million |
CN¥848.28 Million ≈ $124.13 Million |
0.190x | -12.18% |
| 2009-12-31 | CN¥3.95 Billion ≈ $578.22 Million |
CN¥855.05 Million ≈ $125.12 Million |
0.216x | -33.85% |
| 2008-12-31 | CN¥3.41 Billion ≈ $499.38 Million |
CN¥1.12 Billion ≈ $163.36 Million |
0.327x | +55.83% |
| 2007-12-31 | CN¥2.88 Billion ≈ $421.94 Million |
CN¥605.30 Million ≈ $88.57 Million |
0.210x | +25.56% |
| 2006-12-31 | CN¥2.55 Billion ≈ $372.44 Million |
CN¥425.51 Million ≈ $62.26 Million |
0.167x | +1652.24% |
| 2005-12-31 | CN¥2.39 Billion ≈ $350.07 Million |
CN¥22.83 Million ≈ $3.34 Million |
0.010x | +103.03% |
| 2004-12-31 | CN¥2.29 Billion ≈ $334.78 Million |
CN¥-719.63 Million ≈ $-105.30 Million |
-0.315x | -3563.86% |
| 2003-12-31 | CN¥3.09 Billion ≈ $452.72 Million |
CN¥28.09 Million ≈ $4.11 Million |
0.009x | -94.69% |
| 2002-12-31 | CN¥2.90 Billion ≈ $424.65 Million |
CN¥496.12 Million ≈ $72.60 Million |
0.171x | +228.94% |
| 2001-12-31 | CN¥2.95 Billion ≈ $432.00 Million |
CN¥153.44 Million ≈ $22.45 Million |
0.052x | -41.96% |
| 2000-12-31 | CN¥2.98 Billion ≈ $436.10 Million |
CN¥266.86 Million ≈ $39.05 Million |
0.090x | +96.98% |
| 1999-12-31 | CN¥2.65 Billion ≈ $388.31 Million |
CN¥120.63 Million ≈ $17.65 Million |
0.045x | -- |
About China Resources Sanjiu Medical & Pharmaceutical Co Ltd
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in the People's Republic of China and internationally. The company offers health consumer products (CHC), including cold, skin, gastrointestinal, cough, orthopedics, pediatrics drugs, and dietary nutritional supplements; and prescription drug products,… Read more